Gene therapy will be approved by the FDA:

S. Food and Drug Administration regulatory staff said in documents released on Monday. The Swiss drugmaker is seeking FDA approval to market the drug in the United States for acute, uncomplicated malaria infections for people who travel to Africa and

FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder PHILADELPHIA, Nov. 20 /PRNewswire-FirstCall/ --GlaxoSmithKline (NYSE: GSK) today announced that the United

S. Food and Drug Administration regulatory staff said in documents released on Monday. The Swiss drugmaker is seeking FDA approval for the drug, which combines artemether and lumefantrine, to treat acute, uncomplicated malaria infections. If approved,

to severe acute pain,' said John Jenkins, M.D., director of the office of new drugs in the FDA's Center for Drug Evaluation and Research. Tapentadol acts in two ways, opioid (narcotic) and non-opioid. It affects the brain and body primarily by activating

distract viewers from other important safety information about the drugs. Print advertisements already include contact information for the FDA, as required by a law passed last September. The legislation ordered the FDA to report to Congress by late